Large gap with delayed quotes
|
Official
09/15/2025
-
17:35:13
|
Bid
09/15/2025 -
18:30:00
|
Bid Volume |
Ask
09/15/2025 -
18:30:00
|
Ask Volume |
|---|---|---|---|---|
|
16.0700
-0.25
(
-1.53% )
|
15.0000
|
500 |
22.0000
|
6,250 |
Analysis date: 12.09.2025
Global Evaluation
Positive
Positive
The stock is classified in the positive zone since 09.09.2025.
Interest
Strong
Strong
Three stars since 09.09.2025.
Earnings Rev Trend
Negative
Negative
Compared to seven weeks ago, the analysts have lowered their earnings per share estimates. This negative trend began 26.08.2025 at a price of 1820.00.
Evaluation
Strongly undervalued
Strongly undervalued
Based on its growth potential and our own criteria, we believe the share price is currently undervalued.
MT Tech Trend
Negative
Negative
The stock appears oversold from a technical perspective due to its recent losses. It trades below its forty day technical trend since 01.07.2025.
4wk Rel Perf
-8.48%
-8.48%
The stock appears oversold from a technical perspective, with a four week dividend-adjusted underperformance of of 8.48% behind the STOXX600.
Sensibility
Low
Low
Low, no change over 1 year.
Bear Market Factor
Low
Low
On average, the stock has a tendency to minimize the drops in the index by -0.41%.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 2.39%.
Mkt Cap in $bn
4.87
4.87
With a market capitalization between $2 & $8bn, HIKMA PHARMACEUTICALS is considered a mid-cap stock.
G/PE Ratio
1.60
1.60
A "Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings" ratio higher than 1.5 indicates that the stock's price presents a discount to growth >40% in this case.
LT P/E
8
8
The estimated PE is for the year 2027.
LT Growth
8.82%
8.82%
The annualized growth estimate is for the current year to 2027.
Avg. Nb analysts
10
10
Over the last seven weeks, an average of 10 analysts provided earnings per share estimates.
Dividend Yield
3.94%
3.94%
The twelve month estimated dividend yield represents 31.54% of earnings forecasts.
Beta
49
49
For 1% of index variation, the stock varies on average by 0.49%.
Correlation
0.31
0.31
Stock movements are strongly independent of index variations.
Value at Risk
98.08
98.08
The value at risk is estimated at GBp 98.08. The risk is therefore 6.01%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
11.10.2006
11.10.2006